Monoclonal antibodies directed to CD20 and HLA-DR can elicit homotypic adhesion followed by lysosome-mediated cell death in human lymphoma and leukemia cells.

2.50
Hdl Handle:
http://hdl.handle.net/10541/85227
Title:
Monoclonal antibodies directed to CD20 and HLA-DR can elicit homotypic adhesion followed by lysosome-mediated cell death in human lymphoma and leukemia cells.
Authors:
Ivanov, Andrei; Beers, Stephen A; Walshe, Claire A; Honeychurch, Jamie; Alduaij, Waleed; Cox, Kerry L; Potter, Kathleen N; Murray, Stephen M; Chan, Claude H T; Klymenko, Tetyana; Erenpreisa, Jekaterina; Glennie, Martin J; Illidge, Timothy M ( 0000-0003-3191-7324 ) ; Cragg, Mark S
Abstract:
mAbs are becoming increasingly utilized in the treatment of lymphoid disorders. Although Fc-FcgammaR interactions are thought to account for much of their therapeutic effect, this does not explain why certain mAb specificities are more potent than others. An additional effector mechanism underlying the action of some mAbs is the direct induction of cell death. Previously, we demonstrated that certain CD20-specific mAbs (which we termed type II mAbs) evoke a nonapoptotic mode of cell death that appears to be linked with the induction of homotypic adhesion. Here, we reveal that peripheral relocalization of actin is critical for the adhesion and cell death induced by both the type II CD20-specific mAb tositumomab and an HLA-DR-specific mAb in both human lymphoma cell lines and primary chronic lymphocytic leukemia cells. The cell death elicited was rapid, nonapoptotic, nonautophagic, and dependent on the integrity of plasma membrane cholesterol and activation of the V-type ATPase. This cytoplasmic cell death involved lysosomes, which swelled and then dispersed their contents, including cathepsin B, into the cytoplasm and surrounding environment. The resulting loss of plasma membrane integrity occurred independently of caspases and was not controlled by Bcl-2. These experiments provide what we believe to be new insights into the mechanisms by which 2 clinically relevant mAbs elicit cell death and show that this homotypic adhesion-related cell death occurs through a lysosome-dependent pathway.
Affiliation:
CRUK Paterson Institute for Cancer Research, School of Cancer and Imaging Sciences, School of Medicine, University of Manchester, Manchester, United Kingdom.
Citation:
Monoclonal antibodies directed to CD20 and HLA-DR can elicit homotypic adhesion followed by lysosome-mediated cell death in human lymphoma and leukemia cells. 2009, 119 (8):2143-59 J. Clin. Invest.
Journal:
The Journal of Clinical Investigation
Issue Date:
Aug-2009
URI:
http://hdl.handle.net/10541/85227
DOI:
10.1172/JCI37884
PubMed ID:
19620786
Type:
Article
Language:
en
ISSN:
1558-8238
Appears in Collections:
All Paterson Institute for Cancer Research; School of Cancer and Imaging Sciences

Full metadata record

DC FieldValue Language
dc.contributor.authorIvanov, Andreien
dc.contributor.authorBeers, Stephen Aen
dc.contributor.authorWalshe, Claire Aen
dc.contributor.authorHoneychurch, Jamieen
dc.contributor.authorAlduaij, Waleeden
dc.contributor.authorCox, Kerry Len
dc.contributor.authorPotter, Kathleen Nen
dc.contributor.authorMurray, Stephen Men
dc.contributor.authorChan, Claude H Ten
dc.contributor.authorKlymenko, Tetyanaen
dc.contributor.authorErenpreisa, Jekaterinaen
dc.contributor.authorGlennie, Martin Jen
dc.contributor.authorIllidge, Timothy Men
dc.contributor.authorCragg, Mark Sen
dc.date.accessioned2009-11-03T14:21:08Z-
dc.date.available2009-11-03T14:21:08Z-
dc.date.issued2009-08-
dc.identifier.citationMonoclonal antibodies directed to CD20 and HLA-DR can elicit homotypic adhesion followed by lysosome-mediated cell death in human lymphoma and leukemia cells. 2009, 119 (8):2143-59 J. Clin. Invest.en
dc.identifier.issn1558-8238-
dc.identifier.pmid19620786-
dc.identifier.doi10.1172/JCI37884-
dc.identifier.urihttp://hdl.handle.net/10541/85227-
dc.description.abstractmAbs are becoming increasingly utilized in the treatment of lymphoid disorders. Although Fc-FcgammaR interactions are thought to account for much of their therapeutic effect, this does not explain why certain mAb specificities are more potent than others. An additional effector mechanism underlying the action of some mAbs is the direct induction of cell death. Previously, we demonstrated that certain CD20-specific mAbs (which we termed type II mAbs) evoke a nonapoptotic mode of cell death that appears to be linked with the induction of homotypic adhesion. Here, we reveal that peripheral relocalization of actin is critical for the adhesion and cell death induced by both the type II CD20-specific mAb tositumomab and an HLA-DR-specific mAb in both human lymphoma cell lines and primary chronic lymphocytic leukemia cells. The cell death elicited was rapid, nonapoptotic, nonautophagic, and dependent on the integrity of plasma membrane cholesterol and activation of the V-type ATPase. This cytoplasmic cell death involved lysosomes, which swelled and then dispersed their contents, including cathepsin B, into the cytoplasm and surrounding environment. The resulting loss of plasma membrane integrity occurred independently of caspases and was not controlled by Bcl-2. These experiments provide what we believe to be new insights into the mechanisms by which 2 clinically relevant mAbs elicit cell death and show that this homotypic adhesion-related cell death occurs through a lysosome-dependent pathway.en
dc.language.isoenen
dc.subjectLeukaemiaen
dc.subject.meshActins-
dc.subject.meshAntibodies, Monoclonal-
dc.subject.meshAntigens, CD20-
dc.subject.meshApoptosis-
dc.subject.meshAutophagy-
dc.subject.meshCell Adhesion-
dc.subject.meshCell Communication-
dc.subject.meshCell Line-
dc.subject.meshHLA-DR Antigens-
dc.subject.meshHumans-
dc.subject.meshLeukemia-
dc.subject.meshLymphoma-
dc.subject.meshLysosomes-
dc.subject.meshMembrane Microdomains-
dc.subject.meshMicrovilli-
dc.titleMonoclonal antibodies directed to CD20 and HLA-DR can elicit homotypic adhesion followed by lysosome-mediated cell death in human lymphoma and leukemia cells.en
dc.typeArticleen
dc.contributor.departmentCRUK Paterson Institute for Cancer Research, School of Cancer and Imaging Sciences, School of Medicine, University of Manchester, Manchester, United Kingdom.en
dc.identifier.journalThe Journal of Clinical Investigationen

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.